{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:33:01Z","timestamp":1782739981039,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AC21CIII_2\/00002"],"award-info":[{"award-number":["AC21CIII_2\/00002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["EJP RD COFUN-EJP N\u00aa 825575."],"award-info":[{"award-number":["EJP RD COFUN-EJP N\u00aa 825575."]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Epidermolysis bullosa (EB) is a group of rare congenital inherited skin diseases. Evaluation of health-related quality of life (HRQoL) is key to understanding the psychosocial and emotional impact on patients and their relatives or carers. The BUR-EB project aims at ascertaining the socio-economic burden of the disease, including its impact on costs and HRQoL. The aim of this scoping review is to identify which instruments or questionnaires are being used to evaluate the HRQoL of patients with EB and their relatives and carers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A scoping review will be conducted to ascertain the HRQoL of EB patients, their family circle and caregivers over the past 12 years. The wide-ranging review question is as follows: \u201cWhich measurement tools are available for evaluation of HRQoL in EB?\u201d A search will be made in the MEDLINE, WOS and Scopus databases, and the Joanna Briggs Institute methodology will be applied. The data and findings will be shown in tables and in narrative form, in line with the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This scoping review will provide an overview of evidence on the use of HRQoL instruments, both in patients with EB and in relatives and carers. The results of this scoping review will offer a guidance to the researchers to measure the health and well-being of EB patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13643-025-02918-9","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T12:11:04Z","timestamp":1754050264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Health-related quality-of-life evaluation in epidermolysis bullosa: a scoping review protocol"],"prefix":"10.1186","volume":"14","author":[{"given":"Greta","family":"Arias-Merino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Benito-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Linertov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8560-1336","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Alonso-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf the BUR-EB Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"1","key":"2918_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13023-019-1086-5","volume":"14","author":"K Martin","year":"2019","unstructured":"Martin K, Geuens S, Asche JK, et al. Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines. Orphanet J Rare Dis. 2019;14(1):133.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2918_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","volume":"6","author":"A Bardhan","year":"2020","unstructured":"Bardhan A, Bruckner-Tuderman L, Chapple ILC, et al. Epidermolysis bullosa Nat Rev Dis Primers. 2020;6(1):78.","journal-title":"Epidermolysis bullosa Nat Rev Dis Primers"},{"key":"2918_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1750-1172-9-76","volume":"9","author":"M El Hachem","year":"2014","unstructured":"El Hachem M, Zambruno G, Bourdon-Lanoy E, et al. Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet J Rare Dis. 2014;9:76.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2918_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bjd.18921","volume":"183","author":"C Has","year":"2020","unstructured":"Has C, Bauer JW, Bodemer C, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183(4):614\u201327.","journal-title":"Br J Dermatol"},{"issue":"2","key":"2918_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/jdv.18637","volume":"37","author":"C Has","year":"2023","unstructured":"Has C, Hess M, Anem\u00fcller W, et al. Epidemiology of inherited epidermolysis bullosa in Germany. J Eur Acad Dermatol Venereol. 2023;37(2):402\u201310.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2918_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s11136-020-02495-5","volume":"29","author":"CCG Togo","year":"2020","unstructured":"Togo CCG, Zidorio APC, Gon\u00e7alves VSS, et al. Quality of life in people with epidermolysis bullosa: a systematic review. Qual Life Res. 2020;29(7):1731\u201345.","journal-title":"Qual Life Res"},{"issue":"7","key":"2918_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1517\/21678707.2015.1057499","volume":"3","author":"P Serrano-Aguilar","year":"2015","unstructured":"Serrano-Aguilar P, Linertov\u00e1 R, Posada-de-la-Paz M, L\u00f3pez-Bastida J. Recruitment procedures for descriptive socio-economic studies in rare diseases. The BURQOL-RD project. Expert Opin Orphan Drugs. 2015;3(7):759\u201365.","journal-title":"Expert Opin Orphan Drugs"},{"key":"2918_CR8","doi-asserted-by":"crossref","unstructured":"Frew JW, Martin LK, Nijsten T, Murrell DF. Quality of Life Evaluation in Epidermolysis Bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument [published correction appears in Br J Dermatol. 2010 Mar;162(3):701]. Br J Dermatol. 2009;161(6):1323\u20131330.","DOI":"10.1111\/j.1365-2133.2009.09347.x"},{"issue":"6","key":"2918_CR9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1111\/bjd.14072","volume":"173","author":"H Dufresne","year":"2015","unstructured":"Dufresne H, Hadj-Rabia S, Taieb C, Bodemer C. Development and validation of an epidermolysis bullosa family\/parental burden score. Br J Dermatol. 2015;173(6):1405\u201310.","journal-title":"Br J Dermatol"},{"key":"2918_CR10","doi-asserted-by":"crossref","unstructured":"Basra MK, Sue-Ho R, Finlay AY. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease [published correction appears in Br J Dermatol. 2007 Apr;156(4):791]. Br J Dermatol. 2007;156(3):528\u2013538.","DOI":"10.1111\/j.1365-2133.2006.07617.x"},{"issue":"6","key":"2918_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","volume":"132","author":"MS Lewis-Jones","year":"1995","unstructured":"Lewis-Jones MS, Finlay AY. The Children\u2019s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942\u20139.","journal-title":"Br J Dermatol"},{"issue":"4","key":"2918_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/ijd.16197","volume":"62","author":"AV Chateau","year":"2023","unstructured":"Chateau AV, Blackbeard D, Aldous C. The impact of epidermolysis bullosa on the family and healthcare practitioners: a scoping review. Int J Dermatol. 2023;62(4):459\u201375.","journal-title":"Int J Dermatol"},{"key":"2918_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/CCID.S324331","volume":"15","author":"JJ Padniewski","year":"2022","unstructured":"Padniewski JJ, Shaver RL, Schultz B, Pearson DR. Patient quality of life improvement in bullous disease: a review of primary literature and considerations for the clinician. Clin Cosmet Investig Dermatol. 2022;15:27\u201342.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"2918_CR14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s11136-021-02986-z","volume":"31","author":"M Garcia Rodrigues","year":"2022","unstructured":"Garcia Rodrigues M, Monteiro Soares M, Rodrigues JD, et al. Quality of life of parents with children with congenital abnormalities: a systematic review with meta-analysis of assessment methods and levels of quality of life. Qual Life Res. 2022;31(4):991\u20131011.","journal-title":"Qual Life Res"},{"issue":"9","key":"2918_CR15","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/jdv.14288","volume":"31","author":"F Sampogna","year":"2017","unstructured":"Sampogna F, Finlay AY, Salek SS, et al. Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instruments. J Eur Acad Dermatol Venereol. 2017;31(9):1429\u201339.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2918_CR16","doi-asserted-by":"publisher","first-page":"953","DOI":"10.11124\/JBIES-21-00242","volume":"20","author":"MDJ Peters","year":"2022","unstructured":"Peters MDJ, Godfrey C, McInerney P, et al. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. 2022;20(4):953\u201368.","journal-title":"JBI Evid Synth"},{"issue":"1","key":"2918_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/XEB.0000000000000277","volume":"19","author":"MDJ Peters","year":"2021","unstructured":"Peters MDJ, Marnie C, Tricco AC, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Implement. 2021;19(1):3\u201310.","journal-title":"JBI Evid Implement"},{"key":"2918_CR18","doi-asserted-by":"crossref","unstructured":"Peters MDJ, Godfrey C, McInerney P, et al. Chapter 11: Scoping Reviews (2020 version). In: Aromataris E, Munn Z (Editors). JBI Manual for Evidence Synthesis, JBI, 2020. Available from https:\/\/synthesismanual.jbi.global.","DOI":"10.46658\/JBIRM-20-01"},{"issue":"7","key":"2918_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"2918_CR20","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 29 March 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"2918_CR21","doi-asserted-by":"crossref","unstructured":"Zheng S, He A, Yu Y, et al. Research trends and hotspots of health-related quality of life: a bibliometric analysis from 2000 to 2019. Health Qual Life Outcomes. 2021;19(1):130.","DOI":"10.1186\/s12955-021-01767-z"},{"issue":"7","key":"2918_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1023\/A:1013171831202","volume":"10","author":"K Burstr\u00f6m","year":"2001","unstructured":"Burstr\u00f6m K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res. 2001;10(7):621\u201335.","journal-title":"Qual Life Res"},{"issue":"1","key":"2918_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.healthpol.2012.08.001","volume":"108","author":"R Linertov\u00e1","year":"2012","unstructured":"Linertov\u00e1 R, Serrano-Aguilar P, Posada-de-la-Paz M, et al. Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study Health Policy. 2012;108(1):19\u201326.","journal-title":"The BURQOL-RD study Health Policy"},{"key":"2918_CR24","doi-asserted-by":"crossref","unstructured":"Angelis A, Kanavos P, L\u00f3pez-Bastida J, et al. Social\/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe. Eur J Health Econ. 2016;17 Suppl 1(Suppl 1):31\u201342. l","DOI":"10.1007\/s10198-016-0783-4"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02918-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02918-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02918-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:28:14Z","timestamp":1757330894000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-025-02918-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2918"],"URL":"https:\/\/doi.org\/10.1186\/s13643-025-02918-9","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"17 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee (CEIm) of the University Hospital Complex of the Canary Islands (26 January 2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}